Most Popular Articles

1 2 3 4 5

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review

García, Saínza; Martínez-Cengotitabengoa, Mónica; López-Zurbano, Saioa; More

Journal of Clinical Psychopharmacology. 36(4):355-371, August 2016.

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

Limosin, Frédéric; Belhadi, Drifa; Comet, Denis; More

Journal of Clinical Psychopharmacology. 38(1):19-26, February 2018.

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores

Ismail, Zahinoor; Peters-Strickland, Timothy; Miguelez, Maia; More

Journal of Clinical Psychopharmacology. 37(3):347-350, June 2017.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

Fu, Dong-Jing; Turkoz, Ibrahim; Simonson, R. Bruce; More

Journal of Clinical Psychopharmacology. 36(4):372-376, August 2016.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Mazereeuw, Graham; Herrmann, Nathan; Oh, Paul I.; More

Journal of Clinical Psychopharmacology. 36(5):436-444, October 2016.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

Driving Performance Under Alcohol in Simulated Representative Driving Tasks: An Alcohol Calibration Study for Impairments Related to Medicinal Drugs

Kenntner-Mabiala, Ramona; Kaussner, Yvonne; Jagiellowicz-Kaufmann, Monika; More

Journal of Clinical Psychopharmacology. 35(2):134-142, April 2015.

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study

Cressman, Alex M.; Macdonald, Erin M.; Huang, Anjie; More

Journal of Clinical Psychopharmacology. 35(6):667-671, December 2015.

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review

Grall-Bronnec, Marie; Sauvaget, Anne; Perrouin, Fanny; More

Journal of Clinical Psychopharmacology. 36(1):63-70, February 2016.

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in...

Stauffer, Virginia L.; Baygani, Simin K.; Kinon, Bruce J.; More

Journal of Clinical Psychopharmacology. 34(5):552-558, October 2014.

1 2 3 4 5